Women-3 GenerationsOn January 1, 2009, the New England Journal of Medicine published a report from the FDA, which says that the Osteoporosis drug Fosamax may now be linked to cancer. The FDA received 23 reports of esophageal cancer possibly linked to the drug between its October 1995 debut and May 2008. Of these patients, eight have died so far, according to the report. This is worrisome news for the tens of millions of American women that currently take Fosamax for Osteoporosis.